Northwest Investment Counselors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $25.1K | Buy |
+54
| New | +$25.1K | 0.01% | 321 |
|
|
2024
Q2 | – | Sell |
-40
| Closed | -$16.7K | – | 493 |
|
|
2024
Q1 | $16.7K | Buy |
+40
| New | +$16.7K | ﹤0.01% | 335 |
|
|
2023
Q4 | – | Sell |
-48
| Closed | -$16.7K | – | 535 |
|
|
2023
Q3 | $16.7K | Hold |
48
| – | – | ﹤0.01% | 328 |
|
|
2023
Q2 | $16.9K | Buy |
48
+8
| +20% | +$2.82K | ﹤0.01% | 333 |
|
|
2023
Q1 | $12.6K | Hold |
40
| – | – | ﹤0.01% | 376 |
|
|
2022
Q4 | $11.6K | Hold |
40
| – | – | ﹤0.01% | 384 |
|
|
2022
Q3 | $12K | Hold |
40
| – | – | ﹤0.01% | 350 |
|
|
2022
Q2 | $11K | Hold |
40
| – | – | ﹤0.01% | 350 |
|
|
2022
Q1 | $10K | Hold |
40
| – | – | ﹤0.01% | 397 |
|
|
2021
Q4 | $9K | Buy |
+40
| New | +$9K | ﹤0.01% | 376 |
|
|
2021
Q2 | – | Sell |
-40
| Closed | -$9K | – | 436 |
|
|
2021
Q1 | $9K | Buy |
+40
| New | +$9K | ﹤0.01% | 379 |
|
|
2020
Q4 | – | Sell |
-40
| Closed | -$11K | – | 434 |
|
|
2020
Q3 | $11K | Buy |
+40
| New | +$11K | ﹤0.01% | 319 |
|
|
2019
Q4 | – | Sell |
-40
| Closed | -$7K | – | 487 |
|
|
2019
Q3 | $7K | Buy |
+40
| New | +$7K | ﹤0.01% | 405 |
|